Company performance
Add to research
Current Price
as of Apr 17, 2025$1.30
P/E Ratio
N/A
Market Cap
$34.34M
Description
Add to research
23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcicki in 2006 and is headquartered in San Francisco, CA.
Metrics
Add to research
Overview
- HQSan Francisco, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerME
- Price$1.3+1.56%
Trading Information
- Market cap$34.34M
- Float52.11%
- Average Daily Volume (1m)11,858,635
- Average Daily Volume (3m)4,104,234
- EPS-$15.72
Company
- Revenue$208.77M
- Rev growth (1yr)34.67%
- Net income-$34.28M
- Gross margin55.24%
- EBITDA margin-31.02%
- EBITDA-$18.70M
- EV$65.16M
- EV/Revenue0.31
- P/EN/A
- P/S0.16
- P/B0.55
- Debt/Equity96.53
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset